Stephen Patrick O'Hara

Stephen trained as a microbiologist and has over 50 publications, 70 plus patents, and chapters in a number of books. Whilst a scientist by training Stephen is at heart an entrepreneur with a track record of success in identifying opportunities, raising finance, commercializing products, and taking a number of companies to exit by IPO or trade sale. Stephen has built a number of businesses and was a founder of Acolyte Biomedica which he exited to 3M healthcare in 2007 (at a 32X multiple) whereupon he became a Director of Healthcare. Stephen has been a director of an investment company and is frequently asked to advise on potential investments by institutional investors. Stephen founded OptiBiotix in May 2012, SkinBiotix (subsequently SkinBiotherapeutics plc) in 2015, and ProBiotix health Ltd in 2018, to commercialize opportunities in the immature but evolving microbiome field. Stephen Listed OptiBiotix on the London Stock Exchange in August 2014 and SkinBiotherapeutics in April 2017.